Safety and Toxicity Studies Using Flow Cytometry
For GLP and non-GLP Compliant Applications
Immunomodulatory drug candidates typically undergo safety and toxicology analysis to assess suitability for human use. At present, flow cytometry-based safety and toxicology assays are used in tandem with traditional assays and can be performed under good laboratory practice (GLP) conditions or can be used for non-GLP safety and toxicology assessments.
This white paper provides an overview of how flow cytometry-based assays can be used to improve your safety and toxicity analysis and provide you with information critical to informing preclinical development decisions.